HeXun Biosciences Co (ROCO:6986) Interest Expense : NT$-1.2 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is HeXun Biosciences Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. HeXun Biosciences Co's interest expense for the six months ended in Dec. 2024 was NT$ -0.5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-1.2 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. HeXun Biosciences Co's Operating Income for the six months ended in Dec. 2024 was NT$ 82.8 Mil. HeXun Biosciences Co's Interest Expense for the six months ended in Dec. 2024 was NT$ -0.5 Mil. HeXun Biosciences Co's Interest Coverage for the quarter that ended in Dec. 2024 was 160.69. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

HeXun Biosciences Co Interest Expense Historical Data

The historical data trend for HeXun Biosciences Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeXun Biosciences Co Interest Expense Chart

HeXun Biosciences Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

-1.57

-1.64

-1.85

-1.18

HeXun Biosciences Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial			-0.85	-0.94	-0.91	-0.66	-0.52

HeXun Biosciences Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-1.2 Mil.

HeXun Biosciences Co (ROCO:6986) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

HeXun Biosciences Co's Interest Expense for the six months ended in Dec. 2024 was NT$-0.5 Mil. Its Operating Income for the six months ended in Dec. 2024 was NT$82.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was NT$32.0 Mil.

HeXun Biosciences Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	82.753	/	-0.515
	=	160.69

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. HeXun Biosciences Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.

HeXun Biosciences Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HeXun Biosciences Co Ltd (ROCO:6986) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN

Website

https://www.hexunbio.com

HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.

HeXun Biosciences Co Headlines

No Headlines